A client with cystitis receives a prescription for phenazopyridine. Which information should the nurse explain to the client about its therapeutic effect?

A) Instruct the caregiver to withhold the medication until the dosage can be decreased to ensure the client's sa’ety: Withholding the medication without consulting the healthcare provider may not be appropriate, especially if the client is experiencing improvements in cognitive function. The insomnia may be a temporary side effect that could resolve with continued use or adjustment of the dosage.

B) Notify the healthcare provider that the dosage of the medication may need to be increased to manage the client's in’omnia: Increasing the dosage of rivastigmine to manage insomnia may not be the most appropriate action. It's es’ential to assess the client further and explore other interventions before considering a dosage adjustment.

C) Advise the caregiver that the purpose of the medication is to promote sleep, so a change in medication may be needed: Rivastigmine is not typically used to promote sleep. It is a cholinesterase inhibitor used to treat cognitive symptoms associated with Alzheimer's di’ease. Therefore, advising a change in medication solely based on the client's in’omnia is not appropriate.

D) Explain to the caregiver that insomnia is a common and temporary side effect when the medication is first started: Rivastigmine and other cholinesterase inhibitors may cause insomnia, especially when therapy is initiated. Educating the caregiver about this common side effect helps manage expectations and provides reassurance that the insomnia may improve over time as the client's bo’y adjusts to the medication.

A) Be aware that difficulty sleeping and weight loss may occur: This is the correct answer. Bupropion is associated with potential side effects such as insomnia and weight loss. It is essential for the nurse to inform the client about these possible adverse effects to ensure they are aware and can monitor for them. By being informed, the client can report any concerns promptly to their healthcare provider.

B) Administer each dose with at least 8 ounces (240 ml) of water: While it is generally advisable to take medications with a full glass of water, this instruction is not specifically related to bupropion. Therefore, it is not the most pertinent information for discharge teaching regarding this medication.

C) Consume tyramine-free foods while taking the medicine: This instruction is not relevant to bupropion. Tyramine restriction is typically associated with monoamine oxidase inhibitors (MAOIs), not bupropion.

D) Notify the healthcare provider if experiencing changes in taste: Changes in taste are not commonly associated with bupropion use. While it is important to monitor for and report any unusual symptoms while taking medication, difficulty sleeping and weight loss are more commonly observed adverse effects of bupropion that should be emphasized in discharge teaching for a client prescribed this medication to reduce nicotine cravings.